These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27615023)

  • 1. Comparative Effectiveness of Pharmacologic Interventions for Pulmonary Arterial Hypertension: A Systematic Review and Network Meta-Analysis.
    Jain S; Khera R; Girotra S; Badesch D; Wang Z; Murad MH; Blevins A; Schmidt GA; Singh S; Gerke AK
    Chest; 2017 Jan; 151(1):90-105. PubMed ID: 27615023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medications for the treatment of pulmonary arterial hypertension: a systematic review and network meta-analysis.
    Pitre T; Su J; Cui S; Scanlan R; Chiang C; Husnudinov R; Khalid MF; Khan N; Leung G; Mikhail D; Saadat P; Shahid S; Mah J; Mielniczuk L; Zeraatkar D; Mehta S
    Eur Respir Rev; 2022 Sep; 31(165):. PubMed ID: 35948391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral targeted therapies in the treatment of pulmonary arterial hypertension: a meta-analysis of clinical trials.
    Zheng YG; Ma H; Hu EC; Liu G; Chen G; Xiong CM
    Pulm Pharmacol Ther; 2014 Dec; 29(2):241-9. PubMed ID: 25173912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin for pulmonary arterial hypertension.
    Barnes H; Yeoh HL; Fothergill T; Burns A; Humbert M; Williams T
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012785. PubMed ID: 31042010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis.
    Manzi G; Mariani MV; Filomena D; Recchioni T; Papa S; Scoccia G; Badagliacca R; Vizza CD
    Vascul Pharmacol; 2024 Mar; 154():107280. PubMed ID: 38309551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of endothelin receptor antagonists combined with phosphodiesterase 5 inhibitor in the treatment of pulmonary arterial hypertension: a network meta-analysis].
    Fu WH; Chen PL; Xia JL; Fu L; Shen Y; He WJ; Chen YH; Ren N; Jiang Q; Ma R; Wang T; Wang XN; Zhang NF; Liu CL
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Feb; 45(2):158-170. PubMed ID: 35135085
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and Safety of Pulmonary Arterial Hypertension-specific Therapy in Pulmonary Arterial Hypertension: A Meta-analysis of Randomized Controlled Trials.
    Liu HL; Chen XY; Li JR; Su SW; Ding T; Shi CX; Jiang YF; Zhu ZN
    Chest; 2016 Aug; 150(2):353-66. PubMed ID: 27048870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of endothelin receptor antagonists, alone and in combination therapy, in the pulmonary arterial hypertension-connective tissue disease subtype: A systematic review and meta-analysis.
    Shivakumar S; Thynne TR; Mohammadi L; Burdeniuk C; Mangoni AA
    Int J Rheum Dis; 2020 Oct; 23(10):1276-1287. PubMed ID: 32691518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
    Hoeper MM; Al-Hiti H; Benza RL; Chang SA; Corris PA; Gibbs JSR; Grünig E; Jansa P; Klinger JR; Langleben D; McLaughlin VV; Meyer GMB; Ota-Arakaki J; Peacock AJ; Pulido T; Rosenkranz S; Vizza CD; Vonk-Noordegraaf A; White RJ; Chang M; Kleinjung F; Meier C; Paraschin K; Ghofrani HA; Simonneau G;
    Lancet Respir Med; 2021 Jun; 9(6):573-584. PubMed ID: 33773120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Efficacy and Safety of Targeted Therapies for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Network Meta-Analysis.
    Chen Y; Li F; Luo J; Chen J; Luo P; Li J
    Can Respir J; 2021; 2021():1626971. PubMed ID: 34512819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis.
    Ryerson CJ; Nayar S; Swiston JR; Sin DD
    Respir Res; 2010 Jan; 11(1):12. PubMed ID: 20113497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian Network Meta-analysis of Add-on Drug Therapies Specific for Pulmonary Arterial Hypertension.
    Petrovič M; Locatelli I
    Ann Pharmacother; 2020 May; 54(5):423-433. PubMed ID: 31735058
    [No Abstract]   [Full Text] [Related]  

  • 13. Endothelin receptor antagonists for pulmonary arterial hypertension.
    Liu C; Chen J; Gao Y; Deng B; Liu K
    Cochrane Database Syst Rev; 2009 Jul; (3):CD004434. PubMed ID: 19588356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin receptor antagonists for pulmonary arterial hypertension.
    Liu C; Chen J; Gao Y; Deng B; Liu K
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD004434. PubMed ID: 23450552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect treatment comparison and cost-minimization analysis of riociguat versus selexipag in patients with pulmonary arterial hypertension.
    Ornstová E; Tužil J; Chadimová K; Mlčoch T; Doležal T
    Expert Rev Pharmacoecon Outcomes Res; 2022 Dec; 22(8):1269-1275. PubMed ID: 36121156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis.
    Fu W; He W; Li Y; Chen Y; Liang J; Lei H; Fu L; Chen Y; Ren N; Jiang Q; Shen Y; Ma R; Wang T; Wang X; Zhang N; Xiao D; Liu C
    Drug Deliv; 2021 Dec; 28(1):1007-1019. PubMed ID: 34060401
    [No Abstract]   [Full Text] [Related]  

  • 17. What is the position of pulmonary arterial hypertension-specific drug therapy in patients with Eisenmenger syndrome: A systematic review and meta-analysis.
    Li Q; Kuang HY; Wu YH; Lu TW; Yi QJ
    Medicine (Baltimore); 2019 May; 98(20):e15632. PubMed ID: 31096477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Pharmacological Interventions for Covid-19: A Systematic Review and Network Meta-Analysis.
    De Crescenzo F; Amato L; Cruciani F; Moynihan LP; D'Alò GL; Vecchi S; Saulle R; Mitrova Z; Di Franco V; Addis A; Davoli M
    Front Pharmacol; 2021; 12():649472. PubMed ID: 34012398
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis.
    Manzi G; Mariani MV; Filomena D; Papa S; Recchioni T; Scoccia G; Vizza CD; Badagliacca R
    Int J Cardiol; 2023 Dec; ():131691. PubMed ID: 38158135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of pharmacological interventions for pulmonary arterial hypertension: A network meta-analysis.
    Lin H; Wang M; Yu Y; Qin Z; Zhong X; Ma J; Zhao F; Zhang X
    Pulm Pharmacol Ther; 2018 Jun; 50():1-10. PubMed ID: 29128622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.